Literature DB >> 2453097

Characterization of epitopes on native and denatured forms of herpes simplex virus glycoprotein B.

J M Chapsal1, L Pereira.   

Abstract

Herpes simplex virus 1 glycoprotein B (gB) is an envelope glycoprotein which promotes fusion of virions with the cell membrane. This report characterizes the epitopes on native, disulfide-linked dimers of gB and monomeric forms of the glycoprotein using a panel of monoclonal antibodies. The antibodies were divided into groups, based on immune reactions with denatured or native forms of gB. The first group reacted with discontinuous epitopes assembled on gB dimers but failed to detect native or denatured monomers. In contrast, the second group reacted with denatured gB recognizing continuous epitopes on the parent oligomer and monomeric forms. Comparison of gB dimers formed by HFEM and tsB5 revealed that mutant forms specified altered immunological properties. Analysis of gB made in Vero cells showed that discontinuous epitopes were retained whereas a subset of continuous ones were lost on the cleavage products. Results of this study indicate that more than half of the epitopes on gB are generated by juxtaposing amino acids from one or more gB subunits and differ from continuous epitopes present on both forms of the molecule.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453097     DOI: 10.1016/0042-6822(88)90556-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  Glycoprotein B of herpes simplex virus 2 has more than one intracellular conformation and is altered by low pH.

Authors:  Martin I Muggeridge
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

2.  Oligomer formation of the gB glycoprotein of herpes simplex virus type 1.

Authors:  S L Highlander; W F Goins; S Person; T C Holland; M Levine; J C Glorioso
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Monospecific antibodies to Marek's disease virus antigen B dimer (200 kDa) and monomer (130 and 60 kDa) glycoproteins neutralize virus infectivity and detect the antigen B proteins in infected cell membranes.

Authors:  I Davidson; Y Becker; M Malkinson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Identification of mar mutations in herpes simplex virus type 1 glycoprotein B which alter antigenic structure and function in virus penetration.

Authors:  S L Highlander; D J Dorney; P J Gage; T C Holland; W Cai; S Person; M Levine; J C Glorioso
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Herpes simplex virus type 1 glycoprotein B requires a cysteine residue at position 633 for folding, processing, and incorporation into mature infectious virus particles.

Authors:  S Laquerre; D B Anderson; R Argnani; J C Glorioso
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies.

Authors:  D E Goade; R Bell; T Yamada; G J Mertz; S Jenison
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

7.  Glycoprotein B of herpes simplex virus type 1 oligomerizes through the intermolecular interaction of a 28-amino-acid domain.

Authors:  S Laquerre; S Person; J C Glorioso
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Disulfide bonds of herpes simplex virus type 2 glycoprotein gB.

Authors:  N Norais; D Tang; S Kaur; S H Chamberlain; F R Masiarz; R L Burke; F Marcus
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpesvirus 1.

Authors:  I Rauh; F Weiland; F Fehler; G M Keil; T C Mettenleiter
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

10.  Proteolytic cleavage of bovine herpesvirus 1 (BHV-1) glycoprotein gB is not necessary for its function in BHV-1 or pseudorabies virus.

Authors:  A Kopp; E Blewett; V Misra; T C Mettenleiter
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.